Durect Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Durect with three other
companies in this sector in the United States:
Strongbridge Biopharma plc
sales of $18.03 million
of which 93%
Tetraphase Pharmaceuticals Inc
of which 100%
was Biopharmaceuticals), and
Durect reported sales of $18.56 million
December of 2018.
decrease of 62.2%
versus 2017, when the company's sales were $49.17 million.